Literature DB >> 9391152

Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase.

S F Kash1, R S Johnson, L H Tecott, J L Noebels, R D Mayfield, D Hanahan, S Baekkeskov.   

Abstract

gamma-Aminobutyric acid (GABA), the major inhibitory neurotransmitter in the mammalian brain, is synthesized by two glutamate decarboxylase isoforms, GAD65 and GAD67. The separate role of the two isoforms is unknown, but differences in saturation with cofactor and subcellular localization suggest that GAD65 may provide reserve pools of GABA for regulation of inhibitory neurotransmission. We have disrupted the gene encoding GAD65 and backcrossed the mutation into the C57BL/6 strain of mice. In contrast to GAD67-/- animals, which are born with developmental abnormalities and die shortly after birth, GAD65-/- mice appear normal at birth. Basal GABA levels and holo-GAD activity are normal, but the pyridoxal 5' phosphate-inducible apo-enzyme reservoir is significantly decreased. GAD65-/- mice develop spontaneous seizures that result in increased mortality. Seizures can be precipitated by fear or mild stress. Seizure susceptibility is dramatically increased in GAD65-/- mice backcrossed into a second genetic background, the nonobese diabetic (NOD/LtJ) strain of mice enabling electroencephalogram analysis of the seizures. The generally higher basal brain GABA levels in this backcross are significantly decreased by the GAD65-/- mutation, suggesting that the relative contribution of GABA synthesized by GAD65 to total brain GABA levels is genetically determined. Seizure-associated c-fos-like immunoreactivity reveals the involvement of limbic regions of the brain. These data suggest that GABA synthesized by GAD65 is important in the dynamic regulation of neural network excitability, implicate at least one modifier locus in the NOD/LtJ strain, and present GAD65-/- animals as a model of epilepsy involving GABA-ergic pathways.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9391152      PMCID: PMC28432          DOI: 10.1073/pnas.94.25.14060

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase.

Authors:  H Asada; Y Kawamura; K Maruyama; H Kume; R G Ding; N Kanbara; H Kuzume; M Sanbo; T Yagi; K Obata
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

2.  Two genes encode distinct glutamate decarboxylases.

Authors:  M G Erlander; N J Tillakaratne; S Feldblum; N Patel; A J Tobin
Journal:  Neuron       Date:  1991-07       Impact factor: 17.173

3.  Mapping patterns of c-fos expression in the central nervous system after seizure.

Authors:  J I Morgan; D R Cohen; J L Hempstead; T Curran
Journal:  Science       Date:  1987-07-10       Impact factor: 47.728

4.  Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase.

Authors:  S Baekkeskov; H J Aanstoot; S Christgau; A Reetz; M Solimena; M Cascalho; F Folli; H Richter-Olesen; P De Camilli; P D Camilli
Journal:  Nature       Date:  1990-09-13       Impact factor: 49.962

5.  Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome.

Authors:  M Solimena; F Folli; R Aparisi; G Pozza; P De Camilli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

Review 6.  Stiff-man syndrome updated.

Authors:  T R Lorish; G Thorsteinsson; F M Howard
Journal:  Mayo Clin Proc       Date:  1989-06       Impact factor: 7.616

7.  Regulatory properties of brain glutamate decarboxylase (GAD): the apoenzyme of GAD is present principally as the smaller of two molecular forms of GAD in brain.

Authors:  D L Martin; S B Martin; S J Wu; N Espina
Journal:  J Neurosci       Date:  1991-09       Impact factor: 6.167

8.  Two forms of the gamma-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions.

Authors:  D L Kaufman; C R Houser; A J Tobin
Journal:  J Neurochem       Date:  1991-02       Impact factor: 5.372

9.  High concentration of GABA and high glutamate decarboxylase activity in rat pancreatic islets and human insulinoma.

Authors:  Y Okada; H Taniguchi; C Schimada
Journal:  Science       Date:  1976-11-05       Impact factor: 47.728

10.  GABA and pancreatic beta-cells: colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic-like microvesicles suggests their role in GABA storage and secretion.

Authors:  A Reetz; M Solimena; M Matteoli; F Folli; K Takei; P De Camilli
Journal:  EMBO J       Date:  1991-05       Impact factor: 11.598

View more
  106 in total

Review 1.  Molecular analysis of developmental plasticity in neocortex.

Authors:  E Nedivi
Journal:  J Neurobiol       Date:  1999-10

2.  Absence of long-term depression in the visual cortex of glutamic Acid decarboxylase-65 knock-out mice.

Authors:  Se-Young Choi; Bernardo Morales; Hey-Kyoung Lee; Alfredo Kirkwood
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

3.  Activity-dependent regulation of inhibition via GAD67.

Authors:  C Geoffrey Lau; Venkatesh N Murthy
Journal:  J Neurosci       Date:  2012-06-20       Impact factor: 6.167

4.  Epilepsy and behavioral changes, type 1 diabetes mellitus and a high titer of glutamic acid decarboxylase antibodies.

Authors:  Esther Ganelin-Cohen; Dalit Modan-Moses; Rina Hemi; Hannah Kanety; Bruria Ben-Zeev; Christiane S Hampe
Journal:  Pediatr Diabetes       Date:  2015-12-29       Impact factor: 4.866

Review 5.  Defects at the crossroads of GABAergic signaling in generalized genetic epilepsies.

Authors:  Jing-Qiong Kang
Journal:  Epilepsy Res       Date:  2017-08-26       Impact factor: 3.045

6.  Increased anxiety and altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase.

Authors:  S F Kash; L H Tecott; C Hodge; S Baekkeskov
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

7.  A theory of the transition to critical period plasticity: inhibition selectively suppresses spontaneous activity.

Authors:  Taro Toyoizumi; Hiroyuki Miyamoto; Yoko Yazaki-Sugiyama; Nafiseh Atapour; Takao K Hensch; Kenneth D Miller
Journal:  Neuron       Date:  2013-10-02       Impact factor: 17.173

8.  Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction.

Authors:  Elizabeth M Powell; Daniel B Campbell; Gregg D Stanwood; Caleb Davis; Jeffrey L Noebels; Pat Levitt
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

Review 9.  Using C. elegans to decipher the cellular and molecular mechanisms underlying neurodevelopmental disorders.

Authors:  Carlos Bessa; Patrícia Maciel; Ana João Rodrigues
Journal:  Mol Neurobiol       Date:  2013-03-14       Impact factor: 5.590

10.  Activity-dependent regulation of inhibitory synapse development by Npas4.

Authors:  Yingxi Lin; Brenda L Bloodgood; Jessica L Hauser; Ariya D Lapan; Alex C Koon; Tae-Kyung Kim; Linda S Hu; Athar N Malik; Michael E Greenberg
Journal:  Nature       Date:  2008-09-24       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.